Deciding two connected writ petitions arising from a common Industrial Tribunal Award, the Delhi High Court set aside the Tribunal's direction granting hotel workmen a further…
PharmEasy Sells 10% Stake In Thyrocare For ₹668 Cr
PharmEasy has sold a 10% stake in its diagnostics arm, Thyrocare Technologies, for approximately ₹668 crore. The divestment aims to strengthen liquidity and balance sheet stability while focusing on the company’s core digital healthcare and telemedicine operations. This move is part of PharmEasy’s broader restructuring and capital optimization efforts amid changing investor dynamics.